Credit rating agency, India Ratings & Research, a Fitch Group company, has assigned Wockhardt’s long-term issuer rating of ‘AA’ with stable outlook. Further, for working capital facilities, rating of ‘A1+’ has been assigned.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
